A. Ismaila, D. Shah, M. Schroeder, C. Abreu, Alan A Martin, N. Risebrough
{"title":"告知COPD治疗途径(影响研究)- COPD患者单吸入器三联疗法(FF/UMEC/VI)与FF/VI或UMEC/VI筛查治疗亚组的经济评估-加拿大社会视角","authors":"A. Ismaila, D. Shah, M. Schroeder, C. Abreu, Alan A Martin, N. Risebrough","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2994","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":200907,"journal":{"name":"B35. EPIDEMIOLOGICAL STUDIES AND MANAGEMENT OF COPD","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Informing the Pathway of COPD Treatment (the Impact Study) - Economic Evaluation of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI or UMEC/VI in Patients with COPD by Treatment Subgroups at Screening - A Canadian Societal Perspective\",\"authors\":\"A. Ismaila, D. Shah, M. Schroeder, C. Abreu, Alan A Martin, N. Risebrough\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2994\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":200907,\"journal\":{\"name\":\"B35. EPIDEMIOLOGICAL STUDIES AND MANAGEMENT OF COPD\",\"volume\":\"13 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B35. EPIDEMIOLOGICAL STUDIES AND MANAGEMENT OF COPD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2994\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B35. EPIDEMIOLOGICAL STUDIES AND MANAGEMENT OF COPD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2994","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Informing the Pathway of COPD Treatment (the Impact Study) - Economic Evaluation of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI or UMEC/VI in Patients with COPD by Treatment Subgroups at Screening - A Canadian Societal Perspective